Active ingredientLithium LactateCat. No. P-L076-001CAS 867-55-0Family · Pharmaceutical analytical standards
Lithium
Lithium salts, above all the carbonate, are mood stabilisers used in bipolar disorder: Australian psychiatrist John Cade described their effect on mania in 1949 in Melbourne, and they were approved in the United States in 1970. This family brings together the active ingredient, metabolites and other impurities.
Did you know?Cade noticed the calming effect in the guinea pigs used in his experiments; and because lithium is a natural element that cannot be patented, the medicine was developed by academics without industry sponsorship.
Go to the active ingredient →Active ingredientLithium LactateCat. No. P-L076-001CAS 867-55-0
Impurity(E)-4-Hydroxy-3-methylbut-2-enyl Pyrophosphate Lithium SaltCat. No. P-L076-002CAS 396726-03-7
MetaboliteMevalonic Acid Lithium SaltCat. No. P-L076-003CAS 2618458-93-6
Impurity(R)-Mevalonic acid 5-phosphate lithium saltCat. No. P-L076-005
Impurity2-Deoxy Ribonic Acid Lithium SaltCat. No. P-L076-006
Impurity2-Keto-3-Deoxy-D-Gluconic Acid Lithium SaltCat. No. P-L076-007CAS 1998762-01-8
ImpurityClethodim Lithium SaltCat. No. P-L076-008
ImpurityIsoallolithocholic Acid Lithium SaltCat. No. P-L076-009
ImpurityL-Mevalonic Acid Sodium SaltCat. No. P-L076-010CAS 32652-17-8
Active ingredientLithium carbonateCat. No. P-L076-011CAS 554-13-2
ImpurityLithium PerfluorooctanesulfonateCat. No. P-L076-012CAS 29457-72-5
ImpurityLithium ClavulanateCat. No. P-L076-014CAS 61177-44-4
ImpurityLithium 2-(4-(methylsulfonyl)phenyl)acetateCat. No. P-L076-015CAS 1421227-96-4No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceLithium clavulanate CRSEDQM code L0720000Family LithiumNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.